Please assess the completion status of the following clinical trial:

Trial Title: Evaluating a Novel Web-based Intervention for Breast Cancer Survivors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Eligible are women who~* had breast cancer diagnosed less than 4 years ago, classified as T0-4, N0-1, M0~* completed acute treatment for breast cancer at least 6 month ago. This applies for surgery, chemotherapy or radiation, whichever occurred last. (Prophylactic treatment with anti-hormones like tamoxifen, aromatase-inhibitors or bisphosphonates is allowed).~* are competent in German language~* provide written consent to study procedures~* are willing to provide the discharge letter from oncology (to verify diagnosis and therapies)~Exclusion Criteria:~Women are not eligible if they~* have a prior history of breast cancer (other than the current one) or any other cancer except basal or squamous cell skin cancer~* suffer from the following autoimmune and/or inflammatory diseases: rheumatoid arthritis, lupus erythematodes, psoriasis, multiple sclerosis or inflammatory breast cancer~* have a history of schizophrenia, bipolar disorder, or an established diagnosis of borderline personality disorder~* have elevated current suicide risk~* routinely attend psychotherapy, either 1:1, group-therapy or web-based interaction (at least two sessions per month)~* practice 5 hours or more of vigorous physical activity per week (e.g. training for marathon)~* have cognitive impairment~* abuse alcohol or drugs

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Optimune (Type: EXPERIMENTAL): Optimune is an web-based psychological intervention for women with breast cancer. Beyond established CBT techniques targeting depression, anxiety, and fatigue, this intervention specifically includes elements that have shown effects on markers of immune status and inflammation, including sleep, stress management (e.g., mindfulness-based techniques) and lifestyle optimization (dietary and physical activity advice). Content is continuously adapted to users' concerns and needs. It contains interactive dialogues that can be accessed via computer or smart-phone, illustrations, audio files and motivating text messages. Optional daily text messages with motivational content accompany the program. The program can be accessed for 365 days after registration.
- Care-as-Usual (Type: ACTIVE_COMPARATOR): As in the experimental arm, participants are free to continue to engage with any treatment they require (i.e., CAU). However, they will receive access to Optimune six months post-baseline (i.e., wait list with respect to Optimune access).

Based on this trial design, predict the completion outcome and termination type (if applicable).